Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;24(11):1680-91.
doi: 10.1158/1055-9965.EPI-15-0363. Epub 2015 Sep 9.

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk

Xingyi Guo  1 Jirong Long  1 Chenjie Zeng  1 Kyriaki Michailidou  2 Maya Ghoussaini  3 Manjeet K Bolla  2 Qin Wang  2 Roger L Milne  4 Xiao-Ou Shu  1 Qiuyin Cai  1 Jonathan Beesley  5 Siddhartha P Kar  3 Irene L Andrulis  6 Hoda Anton-Culver  7 Volker Arndt  8 Matthias W Beckmann  9 Alicia Beeghly-Fadiel  1 Javier Benitez  10 William Blot  11 Natalia Bogdanova  12 Stig E Bojesen  13 Hiltrud Brauch  14 Hermann Brenner  15 Louise Brinton  16 Annegien Broeks  17 Thomas Brüning  18 Barbara Burwinkel  19 Hui Cai  1 Sander Canisius  17 Jenny Chang-Claude  20 Ji-Yeob Choi  21 Fergus J Couch  22 Angela Cox  23 Simon S Cross  24 Kamila Czene  25 Hatef Darabi  25 Peter Devilee  26 Arnaud Droit  27 Thilo Dörk  28 Peter A Fasching  29 Olivia Fletcher  30 Henrik Flyger  31 Florentia Fostira  32 Valerie Gaborieau  33 Montserrat García-Closas  34 Graham G Giles  4 Mervi Grip  35 Pascal Guénel  36 Christopher A Haiman  37 Ute Hamann  38 Mikael Hartman  39 Antoinette Hollestelle  40 John L Hopper  41 Chia-Ni Hsiung  42 Hidemi Ito  43 Anna Jakubowska  44 Nichola Johnson  30 Maria Kabisch  38 Daehee Kang  45 Sofia Khan  46 Julia A Knight  47 Veli-Matti Kosma  48 Diether Lambrechts  49 Loic Le Marchand  50 Jingmei Li  25 Annika Lindblom  51 Artitaya Lophatananon  52 Jan Lubinski  44 Arto Mannermaa  48 Siranoush Manoukian  53 Sara Margolin  54 Frederik Marme  55 Keitaro Matsuo  56 Catriona A McLean  57 Alfons Meindl  58 Kenneth Muir  59 Susan L Neuhausen  60 Heli Nevanlinna  46 Silje Nord  61 Janet E Olson  62 Nick Orr  63 Paolo Peterlongo  64 Thomas Choudary Putti  65 Anja Rudolph  20 Suleeporn Sangrajrang  66 Elinor J Sawyer  67 Marjanka K Schmidt  17 Rita K Schmutzler  68 Chen-Yang Shen  69 Jiajun Shi  1 Martha J Shrubsole  1 Melissa C Southey  70 Anthony Swerdlow  71 Soo Hwang Teo  72 Bernard Thienpont  49 Amanda Ewart Toland  73 Robert A E M Tollenaar  74 Ian P M Tomlinson  75 Thérèse Truong  36 Chiu-Chen Tseng  37 Ans van den Ouweland  76 Wanqing Wen  1 Robert Winqvist  77 Anna Wu  37 Cheng Har Yip  78 M Pilar Zamora  79 Ying Zheng  80 Per Hall  25 Paul D P Pharoah  81 Jacques Simard  27 Georgia Chenevix-Trench  5 kConFab InvestigatorsAlison M Dunning  3 Douglas F Easton  81 Wei Zheng  82
Affiliations

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk

Xingyi Guo et al. Cancer Epidemiol Biomarkers Prev. 2015 Nov.

Abstract

Background: A recent association study identified a common variant (rs9790517) at 4q24 to be associated with breast cancer risk. Independent association signals and potential functional variants in this locus have not been explored.

Methods: We conducted a fine-mapping analysis in 55,540 breast cancer cases and 51,168 controls from the Breast Cancer Association Consortium.

Results: Conditional analyses identified two independent association signals among women of European ancestry, represented by rs9790517 [conditional P = 2.51 × 10(-4); OR, 1.04; 95% confidence interval (CI), 1.02-1.07] and rs77928427 (P = 1.86 × 10(-4); OR, 1.04; 95% CI, 1.02-1.07). Functional annotation using data from the Encyclopedia of DNA Elements (ENCODE) project revealed two putative functional variants, rs62331150 and rs73838678 in linkage disequilibrium (LD) with rs9790517 (r(2) ≥ 0.90) residing in the active promoter or enhancer, respectively, of the nearest gene, TET2. Both variants are located in DNase I hypersensitivity and transcription factor-binding sites. Using data from both The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), we showed that rs62331150 was associated with level of expression of TET2 in breast normal and tumor tissue.

Conclusion: Our study identified two independent association signals at 4q24 in relation to breast cancer risk and suggested that observed association in this locus may be mediated through the regulation of TET2.

Impact: Fine-mapping study with large sample size warranted for identification of independent loci for breast cancer risk.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1. Regional plot of genetic variants associated with breast cancer risk at 4q24
A) The index SNP rs9790517 is plotted in diamond purple. The LD (r2) for the index SNP with each SNP was computed based on European ancestry subjects included in the 1000 Genome Mar 2012 EUR. P values were from the single-marker analysis based on logistic regression models after adjusted for age, study sites and the first six principal components plus one additional principal component for the LMBC in analyses of data from European descendants. The plot was generated using LocusZoom (50).
Figure 2
Figure 2. Functional annotation of SNPs association with breast cancer risk at 4q24
A) Epigenetic landscape at 4q24 risk locus for breast cancer. From top to bottom, RefSeq genes (TET2 and PPA2), layered H3K4Me1, H3K4Me3 and H3K27Ac histone modifications, DNase clusters, annotation using chromatin states on the ENCODE cell lines, and H3K27Ac histone modification in MCF-7, predicted enhancers reported in the Hnisz et al. study, regulatory elements of enhancers associated with TSS and TSSs from the FANTOM5 project and ChIA-PET interactions in MCF-7 cell (mediated by RNA polymerase 2) between enhancers and TET2 promoter are shown. The signals of different layered histone modifications from the same ENCODE cell line are shown in the same color (The detailed color scheme for each ENCODE cell line described in the UCSC genome browser). The red and orange colors in chromatin states refer to active promoter and strong enhancer regions, respectively (The detailed color scheme of the chromatin states described in the previous study (27)). For ChIA-PET track, black lines represented interactions with the promoter region (−1500/+500) of TET2, and gray lines represent chromatin interactions that do not involve the TET2 promoter region. Purple and green lines represent interactions within +/− 500pb of rs73838678 and rs62331150 variants, respectively. B) Epigenetic signals of two potential functional variants rs73838678 and rs62331150. From top to bottom, lanes showing that the variant mapped to TF predicted binding motifs, TF ChIP-Seq binding peaks and DNase I hypersensitivity sites. The corresponding location of the variant is indicated by dashed line. C) LD plot for breast cancer risk associated SNPs at 4q24. In the top lane, two SNPs representing independent association signals are indicated by the black arrows. The index SNP is indicated by the red arrow. In the bottom lane, two LD SNP blocks were shown based on r2 values, which were computed based on the genotype data from the BCAC.
Figure 3
Figure 3. The association between SNP rs62331150 and TET2 expression in breast cancer tissues from TCGA
The reference allele G of rs62331150 is significantly associated with the increased gene expression relative to the risk allele T.

References

    1. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature genetics. 2013;45:353–361. 61e1-2. - PMC - PubMed
    1. iCOGs [Internet] Cambridge (UK): Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care/Department of Oncology, University of Cambridge; Available from: http://ccge.medschl.cam.ac.uk/research/consortia/icogs/
    1. Tefferi A, Lim KH, Levine R. Mutation in TET2 in myeloid cancers. The New England journal of medicine. 2009;361:1117. author reply -8. - PubMed
    1. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, et al. Mutation in TET2 in myeloid cancers. The New England journal of medicine. 2009;360:2289–2301. - PubMed
    1. Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England journal of medicine. 2013;368:2059–2074. - PMC - PubMed

Publication types

Substances

Grants and funding